In your state


In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.


Economic Impact In Your State: California

The overall economic impact of the biopharmaceutical industry on the U.S. economy is substantial. The biopharmaceutical industry accounted for more than $1.3 trillion in economic output, representing 4.0 percent of total U.S. output in 2015. This total economic impact includes $558 billion in revenues from biopharmaceutical businesses and $659 billion from suppliers and worker spending.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.